Advanced tech company, PhaseV, has raised $15 million in funding

Advanced tech company, PhaseV, has raised $15 million in funding that it says it will use to ‘push the boundaries of machine learning for clinical trial optimization’.

Related Keywords

Zvika Orron ,Miriam Kidron ,Raviv Pryluk ,Noam Ohana ,Deloitte ,Oramed Pharmaceuticals Inc ,Viola Ventures ,Exor Ventures ,Pharmaceuticals Inc ,Markets Amp Regulations ,Funding ,Investment ,Machine Learning ,Research ,Clinical Trial ,Ptimization ,